Ads
related to: otezla patient information leaflet fda reviews mayo clinic- Dosing & Administration
Find Convenient Dosing Schedules
To Meet Your Patients Needs.
- COSENTYX® Treatment
Learn About How COSENTYX®
Treats Multiple Conditions Here.
- COSENTYX® Safety
Learn About The Robust Safety
Profile On The HCP Website.
- Mechanism Of Action
See How COSENTYX® Works &
How It May Help Your Patients.
- Physician Resources
Access Helpful Resources To Get
Patients Started On COSENTYX®.
- Clinical Trial Data
Review Long-Term Clinical Trial
Data & See Efficacy Information.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. [4] The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). [ 4 ]
In Europe, the technical document is called the "summary of product characteristics" (SmPC), and the document for end-users is called the "patient information leaflet" (PIL) or "package leaflet". [3] Similar documents attached to the outside of a package are sometimes called outserts. [citation needed]
However, "PubMed Health, a portal for systematic reviews as well as consumer health information, was discontinued on October 31, 2018. The same or similar content is being provided through other NLM resources, namely PubMed and Bookshelf (for systematic review content), and MedlinePlus (for consumer health information)."
For premium support please call: 800-290-4726 more ways to reach us
Ofatumumab is a fully human monoclonal antibody to CD20, which appears to provide rapid B-cell depletion. [13] Under the brand name Kesimpta, it is approved for the treatment of multiple sclerosis in the United States as well as in the European Union and other regions.
In 2011, the organization changed its name and the name of its affiliates to Mayo Clinic Health System. [8] [9] By 2012, the health system had 70 locations and reported seeing 500,000 patients annually. [10] Prathibha Varkey was named president of Mayo Clinic Health System in 2021; she succeeded Bobbie Gostout.
Ads
related to: otezla patient information leaflet fda reviews mayo clinic